{"id":11075,"date":"2025-05-15T07:41:00","date_gmt":"2025-05-15T07:41:00","guid":{"rendered":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/"},"modified":"2025-05-15T07:41:00","modified_gmt":"2025-05-15T07:41:00","slug":"%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80","status":"publish","type":"post","link":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/","title":{"rendered":"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e"},"content":{"rendered":"<p>\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540e\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u60a3\u8005\u7ef4\u6301\u6cbb\u7597\u7684\u6700\u65b02\u5e74\u957f\u671f\u968f\u8bbf\u6570\u636e\uff0c\u5c06\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u5728ICML\u5927\u4f1a\u516c\u5e03<span class=\"xn-money\">DZD8586<\/span>\u9488\u5bf9\u7ecfBTK\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7814\u7a76\u6210\u679c\u8fde\u83b7ASCO\u548cICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a<\/p>\n<p><span class=\"legendSpanClass\">\u4e0a\u6d77<\/span><span class=\"legendSpanClass\">2025\u5e745\u670815\u65e5<\/span> \/\u7f8e\u901a\u793e\/ &#8212;<span>\u00a02025\u5e745\u670815\u65e5<\/span>\uff0c\u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u5c06\u4e8e\u4eca\u5e746\u6708\u4e3e\u884c\u7684\u8840\u6db2\u5b66\u9886\u57df\u4e24\u5927\u56fd\u9645\u9876\u5c16\u5b66\u672f\u76db\u4f1a\u2014\u20142025\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\uff08EHA\uff09\u5e74\u4f1a\u4ee5\u53ca\u7b2c18\u5c4a\u56fd\u9645\u6076\u6027\u6dcb\u5df4\u7624\u4f1a\u8bae\uff08ICML\uff09\u4e0a\uff0c\u516c\u5e03\u5176\u8840\u6db2\u80bf\u7624\u7ba1\u7ebf\u4e2d8\u9879\u7814\u7a76\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\u3002\u5373\u5c06\u5728\u5927\u4f1a\u4eae\u76f8\u7684\u4e24\u5927\u6838\u5fc3\u4ea7\u54c1\u9ad8\u745e\u54f2\u00ae\uff08\u901a\u7528\u540d\uff1a\u6208\u5229\u6614\u66ff\u5c3c\u80f6\u56ca\uff09\u548cDZD8586\u5728\u6dcb\u5df4\u7624\u9886\u57df\u7684\u7814\u7a76\u8fdb\u5c55\uff0c\u81ea\u4eca\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u6765\uff0c\u63a5\u8fde\u65a9\u83b7\u4e86\u4e09\u9879\u53e3\u5934\u62a5\u544a\u3002<\/p>\n<div class=\"PRN_ImbeddedAssetReference\">\n<p>\n                        <a href=\"https:\/\/mma.prnewswire.com\/media\/2687166\/1.html\" target=\"_blank\" rel=\"noopener\"><\/a><\/p>\n<p>                        \n                <\/p>\n<\/div>\n<p class=\"prntaj\"><span>\u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a\u201c\u9ad8\u745e\u54f2\u00ae\u548cDZD8586\u662f\u8fea\u54f2\u6df1\u8015\u8840\u6db2\u7624\u9886\u57df\u7684\u6838\u5fc3\u7ba1\u7ebf\uff0c\u5f88\u9ad8\u5174\u770b\u5230\u79ef\u6781\u7684\u4e34\u5e8a\u6570\u636e\u4e0d\u65ad\u79ef\u7d2f\uff0c\u6301\u7eed\u9a8c\u8bc1\u4e86\u8fd9\u4e24\u6b3e\u6e90\u5934\u521b\u65b0\u836f\u7269\u4e3a\u60a3\u8005\u5e26\u6765\u7684\u4e34\u5e8a\u83b7\u76ca\uff0c\u5e76\u5f15\u53d1\u56fd\u9645\u5b66\u672f\u754c\u7684\u9ad8\u5ea6\u5173\u6ce8\u4e0e\u8ba4\u53ef\u3002\u201d<\/span><\/p>\n<p>\u9ad8\u745e\u54f2\u00ae\u4e00\u9879\u2161\u671f\u524d\u77bb\u6027\u591a\u4e2d\u5fc3\u4e34\u5e8a\u7814\u7a76JACKPOT26\u7684\u6700\u65b02\u5e74\u968f\u8bbf\u6570\u636e\u5165\u9009\u672c\u6b21EHA\u5927\u4f1a\uff0c\u5e76\u540c\u65f6\u83b7ICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a\u3002\u8be5\u7814\u7a76\u65e8\u5728\u8bc4\u4f30\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6027\u6cbb\u7597\u540e\u7f13\u89e3\u7684\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u7ef4\u6301\u6cbb\u7597\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u7ed3\u679c\u663e\u793a\uff0c\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u7ecf\u4e00\u7ebf\u6cbb\u7597\u540e\u7684PTCL\u60a3\u8005\uff0c\u53ef\u6709\u6548\u7ef4\u6301\u7597\u6548\u5e76\u52a0\u6df1\u80bf\u7624\u7f13\u89e3\uff0c\u4e14\u5b89\u5168\u6027\u53ef\u63a7\u3002<\/p>\n<p>PTCL\u60a3\u8005\u5728\u7ecf\u8fc7\u4e00\u7ebf\u6807\u51c6\u6cbb\u7597\u540e\uff0c\u7ea640%\u7684\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u60a3\u8005\u548c80%\u7684\u90e8\u5206\u7f13\u89e3\uff08PR\uff09\u60a3\u8005\u5728\u80bf\u7624\u7f13\u89e3\u540e\u7684\u4e24\u5e74\u5185\u4f1a\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u60a3\u8005\u590d\u53d1\u98ce\u9669\u9ad8\u4e14\u9884\u540e\u5dee\uff0c\u76ee\u524d\u5c1a\u65e0\u6807\u51c6\u7684\u7ef4\u6301\u6cbb\u7597\u65b9\u6848\u3002\u4eca\u5e744\u6708\uff0c\u5728\u6700\u65b0\u53d1\u5e03\u7684\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08CSCO\uff09\u6dcb\u5df4\u7624\u8bca\u7597\u6307\u5357\uff082025\u7248\uff09\u300b\u4e2d\uff0c\u63d0\u53ca\u4e86\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9PTCL\u7ef4\u6301\u6cbb\u7597\u7684\u63a2\u7d22\u3002<\/p>\n<p class=\"prntaj\"><span>\u6b64\u5916\uff0c\u8fea\u54f2\u533b\u836f\u8fd8\u5c06\u516c\u5e03\u9ad8\u745e\u54f2<\/span><span>\u00ae\u8054\u5408CHOP\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597PTCL\u7684\u521d\u6b65\u79ef\u6781\u6210\u679c\uff0c\u4ee5\u53ca\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u590d\u53d1\/\u96be\u6cbbT\u7ec6\u80de\u5927\u9897\u7c92\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\uff08r\/r T-LGLL\uff09\u3001\u6cbb\u7597r\/r PTCL\u7684\u771f\u5b9e\u4e16\u754c\u7814\u7a76\u3001\u8054\u5408CHOP\u65b9\u6848\u6cbb\u7597\u521d\u6cbb\u5355\u5f62\u6027\u55dc\u4e0a\u76ae\u6027\u80a0\u9053T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MEITL\uff09\u7b49T\u7ec6\u80de\u6dcb\u5df4\u7624\u9886\u57df\u7684\u591a\u9879\u4e34\u5e8a\u8bd5\u9a8c\u7684\u79ef\u6781\u6570\u636e\u3002<\/span><\/p>\n<p>\u5728B\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\u6cbb\u7597\u9886\u57df\uff0cDZD8586\u4e24\u9879\u7814\u7a76\u6210\u679c\u5747\u63a5\u8fde\u5165\u9009ASCO\u3001EHA\u548cICML\u56fd\u9645\u9876\u5c16\u5b66\u672f\u5927\u4f1a\uff0c\u5176\u4e2d\u4e00\u9879\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7684\u2160\/\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u7684\u6c47\u603b\u5206\u6790\uff0c\u5206\u83b7ASCO\u548cICML\u53e3\u5934\u62a5\u544a\u3002\u7814\u7a76\u8bc1\u660e\uff0cDZD8586\u5728\u65e2\u5f80\u7ecf\u91cd\u5ea6\u6cbb\u7597\u7684CLL\/SLL \u60a3\u8005\u4e2d\u8868\u73b0\u51fa<span>\u663e\u8457\u7684<\/span>\u6297\u80bf\u7624\u6d3b\u6027\uff0c\u4e14\u8010\u53d7\u6027\u826f\u597d\uff0c\u5b89\u5168\u6027\u53ef\u63a7\u3002<\/p>\n<p>\u5165\u9009\u7684\u7814\u7a76\u8fd8\u5305\u62ec\uff0cDZD8586\u5355\u836f\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08r\/r DLBCL\uff09\u7684\u4e00\u9879\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u3002\u7ed3\u679c\u663e\u793a\uff0cDZD8586\u5177\u6709\u826f\u597d\u7684\u6297\u80bf\u7624\u6d3b\u6027\u548c\u5b89\u5168\u6027\uff0c\u6700\u65b0\u7814\u7a76\u6570\u636e\u5c06\u7387\u5148\u5728EHA\u5927\u4f1a\u5c55\u793a\u3002<\/p>\n<p>\u5165\u90092025 ICML\u53e3\u5934\u62a5\u544a\u7814\u7a76\u6458\u8981\u76f8\u5173\u4fe1\u606f\u5982\u4e0b\uff1a<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>\u9ad8\u9009\u62e9\u6027JAK1\u6291\u5236\u5242\u6208\u5229\u6614\u66ff\u5c3c\u7528\u4e8e\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540ePTCL\u60a3\u8005\u7684\u7ef4\u6301\u6cbb\u7597\uff1a2\u671f\u4e34\u5e8a\u7814\u7a76\uff08JACKPOT26\uff09\u6700\u65b0\u7814\u7a76\u8fdb\u5c55<br \/>Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u91d1\u6d01\u6559\u6388\uff08\u6d59\u6c5f\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">\u6458\u8981\u7f16\u53f7\uff1a167<br \/>\u53e3\u5934\u62a5\u544a\u65f6\u95f4\uff1a6\/21\/2025\uff0c10:35\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>DZD8586\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7BTK\u6291\u5236\u5242\u53caBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684CLL\/SLL\u60a3\u8005\u76841\/2\u671f\u7814\u7a76<br \/>Phase 1\/2 Studies of <span class=\"xn-money\">DZD8586<\/span> in CLL\/SLL Patients after Covalent or Non-covalent BTK Inhibitors and BTK Degraders<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u674e\u5efa\u52c7\u6559\u6388\uff08\u6c5f\u82cf\u7701\u4eba\u6c11\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">\u6458\u8981\u7f16\u53f7\uff1a146<br \/>\u53e3\u5934\u62a5\u544a\u65f6\u95f4\uff1a6\/19\/2025\uff0c17:35\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u5176\u5b83\u5165\u90092025 EHA\u3001ICML\u7814\u7a76\u6458\u8981\u76f8\u5173\u4fe1\u606f\u5982\u4e0b\uff1a<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>\u9ad8\u9009\u62e9\u6027JAK1\u6291\u5236\u5242\u6208\u5229\u6614\u66ff\u5c3c\u7528\u4e8e\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540ePTCL\u60a3\u8005\u7684\u7ef4\u6301\u6cbb\u7597\uff1a2\u671f\u4e34\u5e8a\u7814\u7a76\uff08JACKPOT26\uff09\u6700\u65b0\u7814\u7a76\u8fdb\u5c55<br \/>Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u91d1\u6d01\u6559\u6388\uff08\u6d59\u6c5f\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPS1937<br \/>\u58c1\u62a5\u5c55\u793a\u65f6\u95f4\uff1a6\/14\/2025\uff0c18:30 &#8211; 19:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>DZD8586\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7BTK\u6291\u5236\u5242\u53caBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684CLL\/SLL\u60a3\u8005\u76841\/2\u671f\u7814\u7a76<br \/>Phase 1\/2 Studies of <span class=\"xn-money\">DZD8586<\/span> in CLL\/SLL Patients after Covalent or Non-covalent BTK Inhibitors and BTK Degraders<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u674e\u5efa\u52c7\u6559\u6388\uff08\u6c5f\u82cf\u7701\u4eba\u6c11\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPF570<br \/>\u58c1\u62a5\u5c55\u793a\u65f6\u95f4\uff1a6\/13\/2025\uff0c18:30 &#8211; 19:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>DZD8586\uff0c\u4e00\u6b3e\u975e\u5171\u4ef7\u3001\u53ef\u5b8c\u5168\u7a7f\u900f\u8840\u8111\u5c4f\u969c\u7684LYN\/BTK\u53cc\u9776\u70b9\u6291\u5236\u5242\u5355\u836f\u6cbb\u7597r\/r DLBCL\u76842\u671f\u7814\u7a76\uff08TAI-SHAN9\uff09<br \/>Phase 2 Study of <span class=\"xn-money\">DZD8586<\/span>, a Non-Covalent BBB Penetrant LYN\/BTK Dual Inhibitor, as Monotherapy in Relapsed\/Refractory Diffuse Large B-Cell Lymphoma (r\/r DLBCL) (TAI-SHAN9)<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u90b1\u5f55\u8d35\u6559\u6388\uff08\u4e2d\u56fd\u533b\u5b66\u79d1\u5b66\u9662\u8840\u6db2\u75c5\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPF962<br \/>\u58c1\u62a5\u5c55\u793a\u65f6\u95f4\uff1a6\/13\/2025\uff0c18:30 &#8211; 19:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<br \/>ICML\u6458\u8981\u7f16\u53f7\uff1a820<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a6\/15\/2025\uff0c23:59\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>\u6208\u5229\u6614\u66ff\u5c3c\u5355\u836f\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u60f0\u6027T\/NK\u7ec6\u80de\u6dcb\u5df4\u7624\uff1aT-LGLL\u961f\u5217\u7684\u521d\u6b65\u7ed3\u679c<br \/>Golidocitinib Monotherapy in the Treatment of Refractory\/Relapsed Indolent T\/NK-Cell Lymphoma: Preliminary Results from T-LGLL Cohort<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u6613\u6811\u534e\u6559\u6388\uff08\u4e2d\u56fd\u533b\u5b66\u79d1\u5b66\u9662\u8840\u6db2\u75c5\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPF908<br \/>\u58c1\u62a5\u5c55\u793a\u65f6\u95f4\uff1a6\/13\/2025\uff0c18:30 &#8211; 19:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<br \/>ICML\u6458\u8981\u7f16\u53f7\uff1a750<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a6\/15\/2025\uff0c23:59\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>\u6208\u5229\u6614\u66ff\u5c3c\u8054\u5408CHOP\u65b9\u6848\u6cbb\u7597\u65b0\u8bca\u65adPTCL\uff1a1\/2\u671f\u4e34\u5e8a\u8bd5\u9a8c\u7684\u521d\u6b65\u7ed3\u679c<br \/>Golidocitinib Combined with CHOP in Newly-Diagnosed Peripheral T-Cell Lymphoma: Preliminary Results from a Phase 1\/2 Clinical Trial<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u5f20\u8587\u6559\u6388\uff08\u5317\u4eac\u534f\u548c\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPB3228<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a5\/14\/2025\uff0c15:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<br \/>ICML\u6458\u8981\u7f16\u53f7\uff1a751<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a6\/15\/2025\uff0c23:59\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>\u6208\u5229\u6614\u66ff\u5c3c\u6cbb\u7597r\/r PTCL\u7684\u771f\u5b9e\u4e16\u754c\u7814\u7a76\uff1a\u6765\u81ea\u4e2d\u56fd\u533b\u7597\u4e2d\u5fc3\u7684\u56de\u987e\u6027\u6570\u636e<br \/>Real-World Study of Golidocitinib for the Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma: Retrospective Data from Medical Centers in <span class=\"xn-location\">China<\/span><br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u9ec4\u6167\u5f3a\u6559\u6388\uff08\u4e2d\u5c71\u5927\u5b66\u9644\u5c5e\u80bf\u7624\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPB3198<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a5\/14\/2025\uff0c15:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<br \/>ICML\u6458\u8981\u7f16\u53f7\uff1a756<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a6\/15\/2025\uff0c23:59\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>\u6208\u5229\u6614\u66ff\u5c3c\u8054\u5408\u7597\u6cd5\u4f5c\u4e3aPTCL\u7684\u4e00\u7ebf\u6cbb\u7597\uff1a\u5355\u4e2d\u5fc3\u56de\u987e\u6027\u6570\u636e<br \/>Golidocitinib Combination Therapy as First-Line Treatment in PTCL: Retrospective Data from a Single Centre<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u674e\u6587\u745c\u6559\u6388\uff08\u5e7f\u4e1c\u7701\u4eba\u6c11\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\">EHA\u6458\u8981\u7f16\u53f7\uff1aPB3297<br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a5\/14\/2025\uff0c15:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u6458\u8981\u6807\u9898\uff1a<br \/>GOAL\u7814\u7a76\uff1a\u6208\u5229\u6614\u66ff\u5c3c\u8054\u5408CHOP\u65b9\u6848\u9488\u5bf9\u521d\u6cbbMEITL\uff1a\u4e00\u98792\u671f\u591a\u4e2d\u5fc3\u3001\u5355\u81c2\u7814\u7a76\u7684\u521d\u6b65\u7ed3\u679c<br \/>Golidocitinib Combined with CHOP in Treatment-Na\u00efve Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma: preliminary results from a phase 2 multicenter, single-arm GOAL study<br \/>\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u738b\u9ece\u6559\u6388\uff08\u4e0a\u6d77\u4ea4\u901a\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u745e\u91d1\u533b\u9662\uff09<\/p>\n<p class=\"prnml40\"><span>EHA\u6458\u8981\u7f16\u53f7\uff1aPB3256<\/span><br \/>\u6458\u8981\u516c\u5e03\u65f6\u95f4\uff1a5\/14\/2025\uff0c15:30\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09<\/p>\n<p>\u5173\u4e8e\u9ad8\u745e\u54f2\u00ae\uff08\u6208\u5229\u6614\u66ff\u5c3c\u80f6\u56ca\uff09<\/p>\n<p>\u9ad8\u745e\u54f2\u00ae\u662f\u4e00\u6b3e\u8fea\u54f2\u81ea\u4e3b\u7814\u53d1\u7684\u9ad8\u9009\u62e9\u6027Janus\u6fc0\u91761\uff08JAK1\uff09\u6291\u5236\u5242\uff0c\u662f\u5168\u7403\u9996\u4e2a\u4e14\u552f\u4e00\u4f5c\u7528\u4e8eJAK\/STAT\u901a\u8def\u7684PTCL\u65b0\u673a\u5236\u6cbb\u7597\u836f\u7269\uff0c\u4e8e2024\u5e746\u6708\u83b7\u56fd\u5bb6\u836f\u76d1\u5c40\u6279\u51c6\u5728\u4e2d\u56fd\u9996\u53d1\u4e0a\u5e02\uff0c\u9002\u7528\u4e8e\u65e2\u5f80\u81f3\u5c11\u63a5\u53d7\u8fc7\u4e00\u7ebf\u7cfb\u7edf\u6027\u6cbb\u7597\u7684\u590d\u53d1\u6216\u96be\u6cbb\u7684\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08r\/r PTCL\uff09\u6210\u4eba\u60a3\u8005\u3002\u9ad8\u745e\u54f2\u00ae\u83b7\u6279\u9002\u5e94\u75c7\u5df2\u7eb3\u5165\u300a\u56fd\u5bb6\u57fa\u672c\u533b\u7597\u4fdd\u9669\u3001\u5de5\u4f24\u4fdd\u9669\u548c\u751f\u80b2\u4fdd\u9669\u836f\u54c1\u76ee\u5f55\uff082024\u5e74\uff09\u300b\u3002\u00a02025\u5e744\u6708\uff0c\u9ad8\u745e\u54f2\u00ae\u6cbb\u7597r\/r PTCL\u88ab\u5217\u5165\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08CSCO\uff09\u6dcb\u5df4\u7624\u8bca\u7597\u6307\u5357\uff082025\u7248\uff09\u300b\u2160\u7ea7\u63a8\u8350\u65b9\u6848\u3002<\/p>\n<p>\u5173\u4e8e<span class=\"xn-money\">DZD8586<\/span><\/p>\n<p>DZD8586\u662f\u4e00\u6b3e\u5168\u7403\u9996\u521b\u3001\u53ef\u5b8c\u5168\u7a7f\u900f\u8840\u8111\u5c4f\u969c\u7684\u975e\u5171\u4ef7LYN\/BTK\u53cc\u9776\u70b9\u6291\u5236\u5242\uff0c\u5bf9\u5176\u4ed6TEC\u5bb6\u65cf\u6fc0\u9176\uff08TEC\u3001ITK\u3001TXK\u548cBMX\uff09\u5177\u6709\u9ad8\u9009\u62e9\u6027\uff0c\u53ef\u540c\u65f6\u963b\u65ad\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u4f9d\u8d56\u6027\u548c\u975e\u4f9d\u8d56\u6027BCR\u4fe1\u53f7\u901a\u8def\uff0c\u6709\u6548\u6291\u5236\u591a\u79cdB\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\u4e9a\u578b\u7ec6\u80de\u53ca\u80bf\u7624\u52a8\u7269\u6a21\u578b\u7684\u751f\u957f\u3002<\/p>\n<p>\u5c3d\u7ba1\u73b0\u6709BTK\u6291\u5236\u5242\u5bf9\u90e8\u5206B-NHL\u4e9a\u578b\u4e34\u5e8a\u7597\u6548\u663e\u8457\uff0c\u4f46\u8010\u836f\u6027\u4e00\u76f4\u662f\u4e34\u5e8a\u4e00\u5927\u96be\u9898\u3002\u4e3b\u8981\u7531\u4e24\u79cd\u673a\u5236\u5f15\u53d1\uff1a\u4e00\u79cd\u662fC481X BTK\u7a81\u53d8\uff0c\u53e6\u4e00\u79cd\u5219\u662f\u975eBTK\u4f9d\u8d56\u6027BCR\u4fe1\u53f7\u901a\u8def\u6fc0\u6d3b\u3002\u5f53\u524d\uff0c\u5c1a\u65e0\u836f\u7269\u80fd\u540c\u65f6\u5e94\u5bf9\u8fd9\u4e24\u79cd\u8010\u836f\u673a\u5236\u3002\u6b64\u5916\uff0c\u867d\u7136BTK\u964d\u89e3\u5242\u5728\u65e9\u671f\u4e34\u5e8a\u7814\u7a76\u4e2d\u663e\u793a\u4e86\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\uff0c\u7a81\u53d8\u76f8\u5173\u7684\u8010\u836f\u5df2\u6709\u62a5\u9053\uff0c\u4e14\u964d\u89e3\u5242\u76f8\u5173\u7684\u6bd2\u526f\u53cd\u5e94\u53ef\u80fd\u5f71\u54cd\u4e34\u5e8a\u7684\u957f\u671f\u5e94\u7528\u3002\u65e2\u5f80\u2160\u671f\u4e34\u5e8a\u7814\u7a76\u6570\u636e\u663e\u793a\uff0cDZD8586\u5177\u6709\u826f\u597d\u7684\u53e3\u670d\u836f\u4ee3\u52a8\u529b\u5b66\u7279\u5f81\u53ca\u4e2d\u67a2\u795e\u7ecf\u7cfb\u7edf\u6e17\u900f\u80fd\u529b\uff0c\u80fd\u5168\u9762\u963b\u65adBCR\u4fe1\u53f7\u901a\u8def\uff0c\u6cbb\u7597\u7531\u8fd9\u4e24\u79cd\u8010\u836f\u673a\u5236\u5f15\u53d1\u7684B-NHL\uff0c\u5b89\u5168\u6027\u53ca\u8010\u53d7\u6027\u826f\u597d\uff0c\u5e76\u5728\u591a\u79cdB-NHL\u4e9a\u578b\u4e2d\u663e\u793a\u4e86\u4ee4\u4eba\u9f13\u821e\u7684\u7597\u6548\u3002<\/p>\n<p>\u5173\u4e8e\u8fea\u54f2\u533b\u836f<\/p>\n<p>\u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u662f\u4e00\u5bb6\u521b\u65b0\u578b\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u4e13\u6ce8\u4e8e\u6076\u6027\u80bf\u7624\u3001\u514d\u75ab\u6027\u75be\u75c5\u9886\u57df\u521b\u65b0\u7597\u6cd5\u7684\u7814\u7a76\u3001\u5f00\u53d1\u548c\u5546\u4e1a\u5316\u3002\u516c\u53f8\u575a\u6301\u6e90\u5934\u521b\u65b0\u7684\u7814\u53d1\u7406\u5ff5\uff0c\u4ee5\u63a8\u51fa\u5168\u7403\u9996\u521b\u836f\u7269\uff08First-in-class\uff09\u548c\u5177\u6709\u7a81\u7834\u6027\u6f5c\u529b\u7684\u6cbb\u7597\u65b9\u6cd5\u4e3a\u76ee\u6807\uff0c\u65e8\u5728\u586b\u8865\u5168\u7403\u672a\u88ab\u6ee1\u8db3\u7684\u4e34\u5e8a\u9700\u6c42\u3002\u57fa\u4e8e\u884c\u4e1a\u9886\u5148\u7684\u8f6c\u5316\u79d1\u5b66\u548c\u65b0\u836f\u5206\u5b50\u8bbe\u8ba1\u4e0e\u7b5b\u9009\u6280\u672f\u5e73\u53f0\uff0c\u516c\u53f8\u5df2\u5efa\u7acb\u4e86\u4e03\u6b3e\u5177\u5907\u5168\u7403\u7ade\u4e89\u529b\u7684\u4ea7\u54c1\u7ba1\u7ebf\uff0c\u5176\u4e2d\u4e24\u5927\u5904\u4e8e\u5168\u7403\u5173\u952e\u6027\u4e34\u5e8a\u8bd5\u9a8c\u9636\u6bb5\u7684\u9886\u5148\u4ea7\u54c1\uff0c\u5747\u5df2\u5728\u4e2d\u56fd\u83b7\u6279\u4e0a\u5e02\u3002\u6b32\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u5173\u6ce8\u5fae\u4fe1\u516c\u4f17\u53f7\uff1a\u8fea\u54f2Dizal\uff0c\u6216\u8bbf\u95eewww.dizalpharma.com\u3002\u00a0<\/p>\n<p>\u524d\u77bb\u6027\u58f0\u660e<\/p>\n<p>\u672c\u65b0\u95fb\u6240\u53d1\u5e03\u7684\u4fe1\u606f\u4e2d\u53ef\u80fd\u4f1a\u5305\u542b\u67d0\u4e9b\u524d\u77bb\u6027\u8868\u8ff0\u3002\u8fd9\u4e9b\u8868\u8ff0\u672c\u8d28\u4e0a\u5177\u6709\u76f8\u5f53\u98ce\u9669\u548c\u4e0d\u786e\u5b9a\u6027\u3002\u5728\u4f7f\u7528&#8221;\u9884\u671f&#8221;\u3001&#8221;\u76f8\u4fe1&#8221;\u3001&#8221;\u9884\u6d4b&#8221;\u3001&#8221;\u671f\u671b&#8221;\u3001&#8221;\u6253\u7b97&#8221;\u3001&#8221;\u6709\u671b&#8221;\u53ca\u5176\u4ed6\u7c7b\u4f3c\u8bcd\u8bed\u8fdb\u884c\u8868\u8ff0\u65f6\uff0c\u51e1\u4e0e\u672c\u516c\u53f8\u6709\u5173\u7684\uff0c\u76ee\u7684\u5747\u662f\u8981\u6307\u660e\u5176\u5c5e\u524d\u77bb\u6027\u8868\u8ff0\u3002<\/p>\n<p>\u524d\u77bb\u6027\u8868\u8ff0\u4e43\u57fa\u4e8e\u672c\u516c\u53f8\u7ba1\u7406\u5c42\u5728\u505a\u51fa\u8868\u8ff0\u65f6\u5bf9\u672a\u6765\u4e8b\u52a1\u7684\u73b0\u6709\u770b\u6cd5\u3001\u5047\u8bbe\u3001\u671f\u671b\u3001\u4f30\u8ba1\u3001\u9884\u6d4b\u548c\u7406\u89e3\u3002\u8fd9\u4e9b\u8868\u8ff0\u5e76\u975e\u5bf9\u672a\u6765\u53d1\u5c55\u7684\u4fdd\u8bc1\uff0c\u4f1a\u53d7\u5230\u98ce\u9669\u3001\u4e0d\u786e\u6027\u53ca\u5176\u4ed6\u56e0\u7d20\u7684\u5f71\u54cd\uff0c\u6709\u4e9b\u4e43\u8d85\u51fa\u672c\u516c\u53f8\u7684\u63a7\u5236\u8303\u56f4\uff0c\u96be\u4ee5\u9884\u8ba1\u3002\u56e0\u6b64\uff0c\u53d7\u6211\u4eec\u7684\u4e1a\u52a1\u3001\u7ade\u4e89\u73af\u5883\u3001\u653f\u6cbb\u3001\u7ecf\u6d4e\u3001\u6cd5\u5f8b\u548c\u793e\u4f1a\u60c5\u51b5\u7684\u672a\u6765\u53d8\u5316\u53ca\u53d1\u5c55\u7684\u5f71\u54cd\uff0c\u5b9e\u9645\u7ed3\u679c\u53ef\u80fd\u4f1a\u4e0e\u524d\u77bb\u6027\u8868\u8ff0\u6240\u542b\u8d44\u6599\u6709\u8f83\u5927\u5dee\u522b\u3002<\/p>\n<p>\u672c\u516c\u53f8\u3001\u672c\u516c\u53f8\u8463\u4e8b\u53ca\u96c7\u5458\u6982\u4e0d\u627f\u62c5\uff08a\uff09\u66f4\u6b63\u6216\u66f4\u65b0\u672c\u7f51\u7ad9\u6240\u8f7d\u524d\u77bb\u6027\u8868\u8ff0\u7684\u4efb\u4f55\u4e49\u52a1\uff1b\u53ca\uff08b\uff09 \u82e5\u56e0\u4efb\u4f55\u524d\u77bb\u6027\u8868\u8ff0\u4e0d\u80fd\u5b9e\u73b0\u6216\u53d8\u6210\u4e0d\u6b63\u786e\u800c\u5f15\u81f4\u7684\u4efb\u4f55\u8d23\u4efb\u3002<\/p>\n<p>\u66f4\u591a\u4fe1\u606f\uff0c\u656c\u8bf7\u8054\u7cfb\u00a0<br \/>\u6295\u8d44\u8005\u5173\u7cfb\uff1a<a href=\"mailto:ir@dizalpharma.com\" target=\"_blank\" rel=\"noopener\">ir@dizalpharma.com<\/a>\u00a0<br \/>\u5546\u52a1\u5408\u4f5c\uff1a<a href=\"mailto:bd@dizalpharma.com\" target=\"_blank\" rel=\"noopener\">bd@dizalpharma.com<\/a><br \/>\u5a92\u4f53\u8054\u7edc\uff1a<a href=\"mailto:pr@dizalpharma.com\" target=\"_blank\" rel=\"noopener\">pr@dizalpharma.com<\/a>\u00a0<\/p>\n<p>\u00a0<\/p>\n<p>SOURCE  \u8fea\u54f2\u533b\u836f<\/p>","protected":false},"excerpt":{"rendered":"<p>\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540e\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u60a3\u8005\u7ef4\u6301\u6cbb\u7597\u7684\u6700\u65b02\u5e74\u957f\u671f\u968f\u8bbf\u6570\u636e\uff0c\u5c06\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u5728ICML\u5927\u4f1a\u516c\u5e03DZD8586\u9488\u5bf9\u7ecfBTK\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7814\u7a76\u6210\u679c\u8fde\u83b7ASCO\u548cICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a \u4e0a\u6d772025\u5e745\u670815\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;\u00a02025\u5e745\u670815\u65e5\uff0c\u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u5c06\u4e8e\u4eca\u5e746\u6708\u4e3e\u884c\u7684\u8840\u6db2\u5b66\u9886\u57df\u4e24\u5927\u56fd\u9645\u9876\u5c16\u5b66\u672f\u76db\u4f1a\u2014\u20142025\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\uff08EHA\uff09\u5e74\u4f1a\u4ee5\u53ca\u7b2c18\u5c4a\u56fd\u9645\u6076\u6027\u6dcb\u5df4\u7624\u4f1a\u8bae\uff08ICML\uff09\u4e0a\uff0c\u516c\u5e03\u5176\u8840\u6db2\u80bf\u7624\u7ba1\u7ebf\u4e2d8\u9879\u7814\u7a76\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\u3002\u5373\u5c06\u5728\u5927\u4f1a\u4eae\u76f8\u7684\u4e24\u5927\u6838\u5fc3\u4ea7\u54c1\u9ad8\u745e\u54f2\u00ae\uff08\u901a\u7528\u540d\uff1a\u6208\u5229\u6614\u66ff\u5c3c\u80f6\u56ca\uff09\u548cDZD8586\u5728\u6dcb\u5df4\u7624\u9886\u57df\u7684\u7814\u7a76\u8fdb\u5c55\uff0c\u81ea\u4eca\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u6765\uff0c\u63a5\u8fde\u65a9\u83b7\u4e86\u4e09\u9879\u53e3\u5934\u62a5\u544a\u3002 \u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a\u201c\u9ad8\u745e\u54f2\u00ae\u548cDZD8586\u662f\u8fea\u54f2\u6df1\u8015\u8840\u6db2\u7624\u9886\u57df\u7684\u6838\u5fc3\u7ba1\u7ebf\uff0c\u5f88\u9ad8\u5174\u770b\u5230\u79ef\u6781\u7684\u4e34\u5e8a\u6570\u636e\u4e0d\u65ad\u79ef\u7d2f\uff0c\u6301\u7eed\u9a8c\u8bc1\u4e86\u8fd9\u4e24\u6b3e\u6e90\u5934\u521b\u65b0\u836f\u7269\u4e3a\u60a3\u8005\u5e26\u6765\u7684\u4e34\u5e8a\u83b7\u76ca\uff0c\u5e76\u5f15\u53d1\u56fd\u9645\u5b66\u672f\u754c\u7684\u9ad8\u5ea6\u5173\u6ce8\u4e0e\u8ba4\u53ef\u3002\u201d \u9ad8\u745e\u54f2\u00ae\u4e00\u9879\u2161\u671f\u524d\u77bb\u6027\u591a\u4e2d\u5fc3\u4e34\u5e8a\u7814\u7a76JACKPOT26\u7684\u6700\u65b02\u5e74\u968f\u8bbf\u6570\u636e\u5165\u9009\u672c\u6b21EHA\u5927\u4f1a\uff0c\u5e76\u540c\u65f6\u83b7ICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a\u3002\u8be5\u7814\u7a76\u65e8\u5728\u8bc4\u4f30\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6027\u6cbb\u7597\u540e\u7f13\u89e3\u7684\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u7ef4\u6301\u6cbb\u7597\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u7ed3\u679c\u663e\u793a\uff0c\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u7ecf\u4e00\u7ebf\u6cbb\u7597\u540e\u7684PTCL\u60a3\u8005\uff0c\u53ef\u6709\u6548\u7ef4\u6301\u7597\u6548\u5e76\u52a0\u6df1\u80bf\u7624\u7f13\u89e3\uff0c\u4e14\u5b89\u5168\u6027\u53ef\u63a7\u3002 PTCL\u60a3\u8005\u5728\u7ecf\u8fc7\u4e00\u7ebf\u6807\u51c6\u6cbb\u7597\u540e\uff0c\u7ea640%\u7684\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u60a3\u8005\u548c80%\u7684\u90e8\u5206\u7f13\u89e3\uff08PR\uff09\u60a3\u8005\u5728\u80bf\u7624\u7f13\u89e3\u540e\u7684\u4e24\u5e74\u5185\u4f1a\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u60a3\u8005\u590d\u53d1\u98ce\u9669\u9ad8\u4e14\u9884\u540e\u5dee\uff0c\u76ee\u524d\u5c1a\u65e0\u6807\u51c6\u7684\u7ef4\u6301\u6cbb\u7597\u65b9\u6848\u3002\u4eca\u5e744\u6708\uff0c\u5728\u6700\u65b0\u53d1\u5e03\u7684\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08CSCO\uff09\u6dcb\u5df4\u7624\u8bca\u7597\u6307\u5357\uff082025\u7248\uff09\u300b\u4e2d\uff0c\u63d0\u53ca\u4e86\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9PTCL\u7ef4\u6301\u6cbb\u7597\u7684\u63a2\u7d22\u3002 \u6b64\u5916\uff0c\u8fea\u54f2\u533b\u836f\u8fd8\u5c06\u516c\u5e03\u9ad8\u745e\u54f2\u00ae\u8054\u5408CHOP\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597PTCL\u7684\u521d\u6b65\u79ef\u6781\u6210\u679c\uff0c\u4ee5\u53ca\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u590d\u53d1\/\u96be\u6cbbT\u7ec6\u80de\u5927\u9897\u7c92\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\uff08r\/r T-LGLL\uff09\u3001\u6cbb\u7597r\/r PTCL\u7684\u771f\u5b9e\u4e16\u754c\u7814\u7a76\u3001\u8054\u5408CHOP\u65b9\u6848\u6cbb\u7597\u521d\u6cbb\u5355\u5f62\u6027\u55dc\u4e0a\u76ae\u6027\u80a0\u9053T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MEITL\uff09\u7b49T\u7ec6\u80de\u6dcb\u5df4\u7624\u9886\u57df\u7684\u591a\u9879\u4e34\u5e8a\u8bd5\u9a8c\u7684\u79ef\u6781\u6570\u636e\u3002 \u5728B\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\u6cbb\u7597\u9886\u57df\uff0cDZD8586\u4e24\u9879\u7814\u7a76\u6210\u679c\u5747\u63a5\u8fde\u5165\u9009ASCO\u3001EHA\u548cICML\u56fd\u9645\u9876\u5c16\u5b66\u672f\u5927\u4f1a\uff0c\u5176\u4e2d\u4e00\u9879\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7684\u2160\/\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u7684\u6c47\u603b\u5206\u6790\uff0c\u5206\u83b7ASCO\u548cICML\u53e3\u5934\u62a5\u544a\u3002\u7814\u7a76\u8bc1\u660e\uff0cDZD8586\u5728\u65e2\u5f80\u7ecf\u91cd\u5ea6\u6cbb\u7597\u7684CLL\/SLL \u60a3\u8005\u4e2d\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u80bf\u7624\u6d3b\u6027\uff0c\u4e14\u8010\u53d7\u6027\u826f\u597d\uff0c\u5b89\u5168\u6027\u53ef\u63a7\u3002 \u5165\u9009\u7684\u7814\u7a76\u8fd8\u5305\u62ec\uff0cDZD8586\u5355\u836f\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08r\/r DLBCL\uff09\u7684\u4e00\u9879\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u3002\u7ed3\u679c\u663e\u793a\uff0cDZD8586\u5177\u6709\u826f\u597d\u7684\u6297\u80bf\u7624\u6d3b\u6027\u548c\u5b89\u5168\u6027\uff0c\u6700\u65b0\u7814\u7a76\u6570\u636e\u5c06\u7387\u5148\u5728EHA\u5927\u4f1a\u5c55\u793a\u3002 \u5165\u90092025 ICML\u53e3\u5934\u62a5\u544a\u7814\u7a76\u6458\u8981\u76f8\u5173\u4fe1\u606f\u5982\u4e0b\uff1a \u6458\u8981\u6807\u9898\uff1a\u9ad8\u9009\u62e9\u6027JAK1\u6291\u5236\u5242\u6208\u5229\u6614\u66ff\u5c3c\u7528\u4e8e\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540ePTCL\u60a3\u8005\u7684\u7ef4\u6301\u6cbb\u7597\uff1a2\u671f\u4e34\u5e8a\u7814\u7a76\uff08JACKPOT26\uff09\u6700\u65b0\u7814\u7a76\u8fdb\u5c55Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u91d1\u6d01\u6559\u6388\uff08\u6d59\u6c5f\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09 \u6458\u8981\u7f16\u53f7\uff1a167\u53e3\u5934\u62a5\u544a\u65f6\u95f4\uff1a6\/21\/2025\uff0c10:35\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09 \u6458\u8981\u6807\u9898\uff1aDZD8586\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7BTK\u6291\u5236\u5242\u53caBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684CLL\/SLL\u60a3\u8005\u76841\/2\u671f\u7814\u7a76Phase 1\/2 Studies of DZD8586 in CLL\/SLL Patients after Covalent or Non-covalent [&hellip;]<\/p>\n","protected":false},"author":0,"featured_media":11076,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[25],"tags":[],"class_list":["post-11075","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e - Money Compass CN<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/moneycompass.com.my\/cn\/\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e - Money Compass CN\" \/>\n<meta property=\"og:description\" content=\"\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540e\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u60a3\u8005\u7ef4\u6301\u6cbb\u7597\u7684\u6700\u65b02\u5e74\u957f\u671f\u968f\u8bbf\u6570\u636e\uff0c\u5c06\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u5728ICML\u5927\u4f1a\u516c\u5e03DZD8586\u9488\u5bf9\u7ecfBTK\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7814\u7a76\u6210\u679c\u8fde\u83b7ASCO\u548cICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a \u4e0a\u6d772025\u5e745\u670815\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;\u00a02025\u5e745\u670815\u65e5\uff0c\u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u5c06\u4e8e\u4eca\u5e746\u6708\u4e3e\u884c\u7684\u8840\u6db2\u5b66\u9886\u57df\u4e24\u5927\u56fd\u9645\u9876\u5c16\u5b66\u672f\u76db\u4f1a\u2014\u20142025\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\uff08EHA\uff09\u5e74\u4f1a\u4ee5\u53ca\u7b2c18\u5c4a\u56fd\u9645\u6076\u6027\u6dcb\u5df4\u7624\u4f1a\u8bae\uff08ICML\uff09\u4e0a\uff0c\u516c\u5e03\u5176\u8840\u6db2\u80bf\u7624\u7ba1\u7ebf\u4e2d8\u9879\u7814\u7a76\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\u3002\u5373\u5c06\u5728\u5927\u4f1a\u4eae\u76f8\u7684\u4e24\u5927\u6838\u5fc3\u4ea7\u54c1\u9ad8\u745e\u54f2\u00ae\uff08\u901a\u7528\u540d\uff1a\u6208\u5229\u6614\u66ff\u5c3c\u80f6\u56ca\uff09\u548cDZD8586\u5728\u6dcb\u5df4\u7624\u9886\u57df\u7684\u7814\u7a76\u8fdb\u5c55\uff0c\u81ea\u4eca\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u6765\uff0c\u63a5\u8fde\u65a9\u83b7\u4e86\u4e09\u9879\u53e3\u5934\u62a5\u544a\u3002 \u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a\u201c\u9ad8\u745e\u54f2\u00ae\u548cDZD8586\u662f\u8fea\u54f2\u6df1\u8015\u8840\u6db2\u7624\u9886\u57df\u7684\u6838\u5fc3\u7ba1\u7ebf\uff0c\u5f88\u9ad8\u5174\u770b\u5230\u79ef\u6781\u7684\u4e34\u5e8a\u6570\u636e\u4e0d\u65ad\u79ef\u7d2f\uff0c\u6301\u7eed\u9a8c\u8bc1\u4e86\u8fd9\u4e24\u6b3e\u6e90\u5934\u521b\u65b0\u836f\u7269\u4e3a\u60a3\u8005\u5e26\u6765\u7684\u4e34\u5e8a\u83b7\u76ca\uff0c\u5e76\u5f15\u53d1\u56fd\u9645\u5b66\u672f\u754c\u7684\u9ad8\u5ea6\u5173\u6ce8\u4e0e\u8ba4\u53ef\u3002\u201d \u9ad8\u745e\u54f2\u00ae\u4e00\u9879\u2161\u671f\u524d\u77bb\u6027\u591a\u4e2d\u5fc3\u4e34\u5e8a\u7814\u7a76JACKPOT26\u7684\u6700\u65b02\u5e74\u968f\u8bbf\u6570\u636e\u5165\u9009\u672c\u6b21EHA\u5927\u4f1a\uff0c\u5e76\u540c\u65f6\u83b7ICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a\u3002\u8be5\u7814\u7a76\u65e8\u5728\u8bc4\u4f30\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6027\u6cbb\u7597\u540e\u7f13\u89e3\u7684\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u7ef4\u6301\u6cbb\u7597\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u7ed3\u679c\u663e\u793a\uff0c\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u7ecf\u4e00\u7ebf\u6cbb\u7597\u540e\u7684PTCL\u60a3\u8005\uff0c\u53ef\u6709\u6548\u7ef4\u6301\u7597\u6548\u5e76\u52a0\u6df1\u80bf\u7624\u7f13\u89e3\uff0c\u4e14\u5b89\u5168\u6027\u53ef\u63a7\u3002 PTCL\u60a3\u8005\u5728\u7ecf\u8fc7\u4e00\u7ebf\u6807\u51c6\u6cbb\u7597\u540e\uff0c\u7ea640%\u7684\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u60a3\u8005\u548c80%\u7684\u90e8\u5206\u7f13\u89e3\uff08PR\uff09\u60a3\u8005\u5728\u80bf\u7624\u7f13\u89e3\u540e\u7684\u4e24\u5e74\u5185\u4f1a\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u60a3\u8005\u590d\u53d1\u98ce\u9669\u9ad8\u4e14\u9884\u540e\u5dee\uff0c\u76ee\u524d\u5c1a\u65e0\u6807\u51c6\u7684\u7ef4\u6301\u6cbb\u7597\u65b9\u6848\u3002\u4eca\u5e744\u6708\uff0c\u5728\u6700\u65b0\u53d1\u5e03\u7684\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08CSCO\uff09\u6dcb\u5df4\u7624\u8bca\u7597\u6307\u5357\uff082025\u7248\uff09\u300b\u4e2d\uff0c\u63d0\u53ca\u4e86\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9PTCL\u7ef4\u6301\u6cbb\u7597\u7684\u63a2\u7d22\u3002 \u6b64\u5916\uff0c\u8fea\u54f2\u533b\u836f\u8fd8\u5c06\u516c\u5e03\u9ad8\u745e\u54f2\u00ae\u8054\u5408CHOP\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597PTCL\u7684\u521d\u6b65\u79ef\u6781\u6210\u679c\uff0c\u4ee5\u53ca\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u590d\u53d1\/\u96be\u6cbbT\u7ec6\u80de\u5927\u9897\u7c92\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\uff08r\/r T-LGLL\uff09\u3001\u6cbb\u7597r\/r PTCL\u7684\u771f\u5b9e\u4e16\u754c\u7814\u7a76\u3001\u8054\u5408CHOP\u65b9\u6848\u6cbb\u7597\u521d\u6cbb\u5355\u5f62\u6027\u55dc\u4e0a\u76ae\u6027\u80a0\u9053T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MEITL\uff09\u7b49T\u7ec6\u80de\u6dcb\u5df4\u7624\u9886\u57df\u7684\u591a\u9879\u4e34\u5e8a\u8bd5\u9a8c\u7684\u79ef\u6781\u6570\u636e\u3002 \u5728B\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\u6cbb\u7597\u9886\u57df\uff0cDZD8586\u4e24\u9879\u7814\u7a76\u6210\u679c\u5747\u63a5\u8fde\u5165\u9009ASCO\u3001EHA\u548cICML\u56fd\u9645\u9876\u5c16\u5b66\u672f\u5927\u4f1a\uff0c\u5176\u4e2d\u4e00\u9879\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7684\u2160\/\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u7684\u6c47\u603b\u5206\u6790\uff0c\u5206\u83b7ASCO\u548cICML\u53e3\u5934\u62a5\u544a\u3002\u7814\u7a76\u8bc1\u660e\uff0cDZD8586\u5728\u65e2\u5f80\u7ecf\u91cd\u5ea6\u6cbb\u7597\u7684CLL\/SLL \u60a3\u8005\u4e2d\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u80bf\u7624\u6d3b\u6027\uff0c\u4e14\u8010\u53d7\u6027\u826f\u597d\uff0c\u5b89\u5168\u6027\u53ef\u63a7\u3002 \u5165\u9009\u7684\u7814\u7a76\u8fd8\u5305\u62ec\uff0cDZD8586\u5355\u836f\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08r\/r DLBCL\uff09\u7684\u4e00\u9879\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u3002\u7ed3\u679c\u663e\u793a\uff0cDZD8586\u5177\u6709\u826f\u597d\u7684\u6297\u80bf\u7624\u6d3b\u6027\u548c\u5b89\u5168\u6027\uff0c\u6700\u65b0\u7814\u7a76\u6570\u636e\u5c06\u7387\u5148\u5728EHA\u5927\u4f1a\u5c55\u793a\u3002 \u5165\u90092025 ICML\u53e3\u5934\u62a5\u544a\u7814\u7a76\u6458\u8981\u76f8\u5173\u4fe1\u606f\u5982\u4e0b\uff1a \u6458\u8981\u6807\u9898\uff1a\u9ad8\u9009\u62e9\u6027JAK1\u6291\u5236\u5242\u6208\u5229\u6614\u66ff\u5c3c\u7528\u4e8e\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540ePTCL\u60a3\u8005\u7684\u7ef4\u6301\u6cbb\u7597\uff1a2\u671f\u4e34\u5e8a\u7814\u7a76\uff08JACKPOT26\uff09\u6700\u65b0\u7814\u7a76\u8fdb\u5c55Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u91d1\u6d01\u6559\u6388\uff08\u6d59\u6c5f\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09 \u6458\u8981\u7f16\u53f7\uff1a167\u53e3\u5934\u62a5\u544a\u65f6\u95f4\uff1a6\/21\/2025\uff0c10:35\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09 \u6458\u8981\u6807\u9898\uff1aDZD8586\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7BTK\u6291\u5236\u5242\u53caBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684CLL\/SLL\u60a3\u8005\u76841\/2\u671f\u7814\u7a76Phase 1\/2 Studies of DZD8586 in CLL\/SLL Patients after Covalent or Non-covalent [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/moneycompass.com.my\/cn\/\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\/\" \/>\n<meta property=\"og:site_name\" content=\"Money Compass CN\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-15T07:41:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"144\" \/>\n\t<meta property=\"og:image:height\" content=\"81\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/\",\"name\":\"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e - Money Compass CN\",\"isPartOf\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg\",\"datePublished\":\"2025-05-15T07:41:00+00:00\",\"dateModified\":\"2025-05-15T07:41:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#primaryimage\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg\",\"contentUrl\":\"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg\",\"width\":144,\"height\":81},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/moneycompass.com.my\/cn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/moneycompass.com.my\/cn\/#website\",\"url\":\"https:\/\/moneycompass.com.my\/cn\/\",\"name\":\"Money Compass CN\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e - Money Compass CN","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/moneycompass.com.my\/cn\/\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\/","og_locale":"en_US","og_type":"article","og_title":"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e - Money Compass CN","og_description":"\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540e\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u60a3\u8005\u7ef4\u6301\u6cbb\u7597\u7684\u6700\u65b02\u5e74\u957f\u671f\u968f\u8bbf\u6570\u636e\uff0c\u5c06\u4ee5\u53e3\u5934\u62a5\u544a\u5f62\u5f0f\u5728ICML\u5927\u4f1a\u516c\u5e03DZD8586\u9488\u5bf9\u7ecfBTK\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7814\u7a76\u6210\u679c\u8fde\u83b7ASCO\u548cICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a \u4e0a\u6d772025\u5e745\u670815\u65e5 \/\u7f8e\u901a\u793e\/ &#8212;\u00a02025\u5e745\u670815\u65e5\uff0c\u8fea\u54f2\u533b\u836f\uff08\u80a1\u7968\u4ee3\u7801\uff1a688192.SH\uff09\u5ba3\u5e03\uff0c\u516c\u53f8\u5c06\u4e8e\u4eca\u5e746\u6708\u4e3e\u884c\u7684\u8840\u6db2\u5b66\u9886\u57df\u4e24\u5927\u56fd\u9645\u9876\u5c16\u5b66\u672f\u76db\u4f1a\u2014\u20142025\u6b27\u6d32\u8840\u6db2\u5b66\u534f\u4f1a\uff08EHA\uff09\u5e74\u4f1a\u4ee5\u53ca\u7b2c18\u5c4a\u56fd\u9645\u6076\u6027\u6dcb\u5df4\u7624\u4f1a\u8bae\uff08ICML\uff09\u4e0a\uff0c\u516c\u5e03\u5176\u8840\u6db2\u80bf\u7624\u7ba1\u7ebf\u4e2d8\u9879\u7814\u7a76\u7684\u6700\u65b0\u4e34\u5e8a\u6570\u636e\u3002\u5373\u5c06\u5728\u5927\u4f1a\u4eae\u76f8\u7684\u4e24\u5927\u6838\u5fc3\u4ea7\u54c1\u9ad8\u745e\u54f2\u00ae\uff08\u901a\u7528\u540d\uff1a\u6208\u5229\u6614\u66ff\u5c3c\u80f6\u56ca\uff09\u548cDZD8586\u5728\u6dcb\u5df4\u7624\u9886\u57df\u7684\u7814\u7a76\u8fdb\u5c55\uff0c\u81ea\u4eca\u5e74\u7f8e\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08ASCO\uff09\u5e74\u4f1a\u4ee5\u6765\uff0c\u63a5\u8fde\u65a9\u83b7\u4e86\u4e09\u9879\u53e3\u5934\u62a5\u544a\u3002 \u8fea\u54f2\u533b\u836f\u521b\u59cb\u4eba\u3001\u8463\u4e8b\u957f\u517c\u9996\u5e2d\u6267\u884c\u5b98\u5f20\u5c0f\u6797\u535a\u58eb\u8868\u793a\uff1a\u201c\u9ad8\u745e\u54f2\u00ae\u548cDZD8586\u662f\u8fea\u54f2\u6df1\u8015\u8840\u6db2\u7624\u9886\u57df\u7684\u6838\u5fc3\u7ba1\u7ebf\uff0c\u5f88\u9ad8\u5174\u770b\u5230\u79ef\u6781\u7684\u4e34\u5e8a\u6570\u636e\u4e0d\u65ad\u79ef\u7d2f\uff0c\u6301\u7eed\u9a8c\u8bc1\u4e86\u8fd9\u4e24\u6b3e\u6e90\u5934\u521b\u65b0\u836f\u7269\u4e3a\u60a3\u8005\u5e26\u6765\u7684\u4e34\u5e8a\u83b7\u76ca\uff0c\u5e76\u5f15\u53d1\u56fd\u9645\u5b66\u672f\u754c\u7684\u9ad8\u5ea6\u5173\u6ce8\u4e0e\u8ba4\u53ef\u3002\u201d \u9ad8\u745e\u54f2\u00ae\u4e00\u9879\u2161\u671f\u524d\u77bb\u6027\u591a\u4e2d\u5fc3\u4e34\u5e8a\u7814\u7a76JACKPOT26\u7684\u6700\u65b02\u5e74\u968f\u8bbf\u6570\u636e\u5165\u9009\u672c\u6b21EHA\u5927\u4f1a\uff0c\u5e76\u540c\u65f6\u83b7ICML\u5927\u4f1a\u53e3\u5934\u62a5\u544a\u3002\u8be5\u7814\u7a76\u65e8\u5728\u8bc4\u4f30\u9ad8\u745e\u54f2\u00ae\u7528\u4e8e\u7ecf\u4e00\u7ebf\u7cfb\u7edf\u6027\u6cbb\u7597\u540e\u7f13\u89e3\u7684\u5916\u5468T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08PTCL\uff09\u7ef4\u6301\u6cbb\u7597\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002\u7ed3\u679c\u663e\u793a\uff0c\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u7ecf\u4e00\u7ebf\u6cbb\u7597\u540e\u7684PTCL\u60a3\u8005\uff0c\u53ef\u6709\u6548\u7ef4\u6301\u7597\u6548\u5e76\u52a0\u6df1\u80bf\u7624\u7f13\u89e3\uff0c\u4e14\u5b89\u5168\u6027\u53ef\u63a7\u3002 PTCL\u60a3\u8005\u5728\u7ecf\u8fc7\u4e00\u7ebf\u6807\u51c6\u6cbb\u7597\u540e\uff0c\u7ea640%\u7684\u5b8c\u5168\u7f13\u89e3\uff08CR\uff09\u60a3\u8005\u548c80%\u7684\u90e8\u5206\u7f13\u89e3\uff08PR\uff09\u60a3\u8005\u5728\u80bf\u7624\u7f13\u89e3\u540e\u7684\u4e24\u5e74\u5185\u4f1a\u51fa\u73b0\u75be\u75c5\u8fdb\u5c55\uff0c\u60a3\u8005\u590d\u53d1\u98ce\u9669\u9ad8\u4e14\u9884\u540e\u5dee\uff0c\u76ee\u524d\u5c1a\u65e0\u6807\u51c6\u7684\u7ef4\u6301\u6cbb\u7597\u65b9\u6848\u3002\u4eca\u5e744\u6708\uff0c\u5728\u6700\u65b0\u53d1\u5e03\u7684\u300a\u4e2d\u56fd\u4e34\u5e8a\u80bf\u7624\u5b66\u4f1a\uff08CSCO\uff09\u6dcb\u5df4\u7624\u8bca\u7597\u6307\u5357\uff082025\u7248\uff09\u300b\u4e2d\uff0c\u63d0\u53ca\u4e86\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9PTCL\u7ef4\u6301\u6cbb\u7597\u7684\u63a2\u7d22\u3002 \u6b64\u5916\uff0c\u8fea\u54f2\u533b\u836f\u8fd8\u5c06\u516c\u5e03\u9ad8\u745e\u54f2\u00ae\u8054\u5408CHOP\u65b9\u6848\u4e00\u7ebf\u6cbb\u7597PTCL\u7684\u521d\u6b65\u79ef\u6781\u6210\u679c\uff0c\u4ee5\u53ca\u9ad8\u745e\u54f2\u00ae\u9488\u5bf9\u590d\u53d1\/\u96be\u6cbbT\u7ec6\u80de\u5927\u9897\u7c92\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\uff08r\/r T-LGLL\uff09\u3001\u6cbb\u7597r\/r PTCL\u7684\u771f\u5b9e\u4e16\u754c\u7814\u7a76\u3001\u8054\u5408CHOP\u65b9\u6848\u6cbb\u7597\u521d\u6cbb\u5355\u5f62\u6027\u55dc\u4e0a\u76ae\u6027\u80a0\u9053T\u7ec6\u80de\u6dcb\u5df4\u7624\uff08MEITL\uff09\u7b49T\u7ec6\u80de\u6dcb\u5df4\u7624\u9886\u57df\u7684\u591a\u9879\u4e34\u5e8a\u8bd5\u9a8c\u7684\u79ef\u6781\u6570\u636e\u3002 \u5728B\u7ec6\u80de\u975e\u970d\u5947\u91d1\u6dcb\u5df4\u7624\uff08B-NHL\uff09\u6cbb\u7597\u9886\u57df\uff0cDZD8586\u4e24\u9879\u7814\u7a76\u6210\u679c\u5747\u63a5\u8fde\u5165\u9009ASCO\u3001EHA\u548cICML\u56fd\u9645\u9876\u5c16\u5b66\u672f\u5927\u4f1a\uff0c\u5176\u4e2d\u4e00\u9879\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7\u5e03\u9c81\u987f\u6c0f\u916a\u6c28\u9178\u6fc0\u9176\uff08BTK\uff09\u6291\u5236\u5242\u548cBTK\u964d\u89e3\u5242\u6cbb\u7597\u6162\u6027\u6dcb\u5df4\u7ec6\u80de\u767d\u8840\u75c5\/\u5c0f\u6dcb\u5df4\u7ec6\u80de\u6dcb\u5df4\u7624\uff08CLL\/SLL\uff09\u7684\u2160\/\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u7684\u6c47\u603b\u5206\u6790\uff0c\u5206\u83b7ASCO\u548cICML\u53e3\u5934\u62a5\u544a\u3002\u7814\u7a76\u8bc1\u660e\uff0cDZD8586\u5728\u65e2\u5f80\u7ecf\u91cd\u5ea6\u6cbb\u7597\u7684CLL\/SLL \u60a3\u8005\u4e2d\u8868\u73b0\u51fa\u663e\u8457\u7684\u6297\u80bf\u7624\u6d3b\u6027\uff0c\u4e14\u8010\u53d7\u6027\u826f\u597d\uff0c\u5b89\u5168\u6027\u53ef\u63a7\u3002 \u5165\u9009\u7684\u7814\u7a76\u8fd8\u5305\u62ec\uff0cDZD8586\u5355\u836f\u6cbb\u7597\u590d\u53d1\/\u96be\u6cbb\u5f25\u6f2b\u6027\u5927B\u7ec6\u80de\u6dcb\u5df4\u7624\uff08r\/r DLBCL\uff09\u7684\u4e00\u9879\u2161\u671f\u4e34\u5e8a\u7814\u7a76\u3002\u7ed3\u679c\u663e\u793a\uff0cDZD8586\u5177\u6709\u826f\u597d\u7684\u6297\u80bf\u7624\u6d3b\u6027\u548c\u5b89\u5168\u6027\uff0c\u6700\u65b0\u7814\u7a76\u6570\u636e\u5c06\u7387\u5148\u5728EHA\u5927\u4f1a\u5c55\u793a\u3002 \u5165\u90092025 ICML\u53e3\u5934\u62a5\u544a\u7814\u7a76\u6458\u8981\u76f8\u5173\u4fe1\u606f\u5982\u4e0b\uff1a \u6458\u8981\u6807\u9898\uff1a\u9ad8\u9009\u62e9\u6027JAK1\u6291\u5236\u5242\u6208\u5229\u6614\u66ff\u5c3c\u7528\u4e8e\u4e00\u7ebf\u7cfb\u7edf\u6cbb\u7597\u540ePTCL\u60a3\u8005\u7684\u7ef4\u6301\u6cbb\u7597\uff1a2\u671f\u4e34\u5e8a\u7814\u7a76\uff08JACKPOT26\uff09\u6700\u65b0\u7814\u7a76\u8fdb\u5c55Maintenance Therapy of Golidocitinib, a JAK1 Selective Inhibitor, in Patients with Peripheral T Cell Lymphomas after First-line Systemic Therapy: Updates of the Phase 2 Study (JACKPOT26)\u4e3b\u8981\u7814\u7a76\u8005\uff1a\u91d1\u6d01\u6559\u6388\uff08\u6d59\u6c5f\u5927\u5b66\u533b\u5b66\u9662\u9644\u5c5e\u7b2c\u4e00\u533b\u9662\uff09 \u6458\u8981\u7f16\u53f7\uff1a167\u53e3\u5934\u62a5\u544a\u65f6\u95f4\uff1a6\/21\/2025\uff0c10:35\uff08\u4e2d\u6b27\u590f\u4ee4\u65f6\u95f4\uff09 \u6458\u8981\u6807\u9898\uff1aDZD8586\u9488\u5bf9\u65e2\u5f80\u63a5\u53d7\u8fc7\u5171\u4ef7\u6216\u975e\u5171\u4ef7BTK\u6291\u5236\u5242\u53caBTK\u964d\u89e3\u5242\u6cbb\u7597\u7684CLL\/SLL\u60a3\u8005\u76841\/2\u671f\u7814\u7a76Phase 1\/2 Studies of DZD8586 in CLL\/SLL Patients after Covalent or Non-covalent [&hellip;]","og_url":"https:\/\/moneycompass.com.my\/cn\/\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\/","og_site_name":"Money Compass CN","article_published_time":"2025-05-15T07:41:00+00:00","og_image":[{"width":144,"height":81,"url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/","url":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/","name":"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e - Money Compass CN","isPartOf":{"@id":"https:\/\/moneycompass.com.my\/cn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#primaryimage"},"image":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#primaryimage"},"thumbnailUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg","datePublished":"2025-05-15T07:41:00+00:00","dateModified":"2025-05-15T07:41:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#primaryimage","url":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg","contentUrl":"https:\/\/moneycompass.com.my\/cn\/wp-content\/uploads\/2025\/05\/1-a3yakn.jpeg","width":144,"height":81},{"@type":"BreadcrumbList","@id":"https:\/\/moneycompass.com.my\/cn\/%e5%85%a5%e9%80%89%e5%9b%bd%e9%99%85%e9%a1%b6%e5%b0%96%e5%ad%a6%e6%9c%af%e4%bc%9a%e8%ae%ae%e4%b8%89%e9%a1%b9%e5%8f%a3%e5%a4%b4%e6%8a%a5%e5%91%8a%ef%bc%81%e8%bf%aa%e5%93%b2%e5%8c%bb%e8%8d%af%e8%a1%80\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/moneycompass.com.my\/cn\/"},{"@type":"ListItem","position":2,"name":"\u5165\u9009\u56fd\u9645\u9876\u5c16\u5b66\u672f\u4f1a\u8bae\u4e09\u9879\u53e3\u5934\u62a5\u544a\uff01\u8fea\u54f2\u533b\u836f\u8840\u6db2\u7624\u9886\u57df\u6838\u5fc3\u4ea7\u54c1\u4f18\u52bf\u51f8\u663e"}]},{"@type":"WebSite","@id":"https:\/\/moneycompass.com.my\/cn\/#website","url":"https:\/\/moneycompass.com.my\/cn\/","name":"Money Compass CN","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/moneycompass.com.my\/cn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/11075"}],"collection":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/comments?post=11075"}],"version-history":[{"count":0,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/posts\/11075\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media\/11076"}],"wp:attachment":[{"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/media?parent=11075"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/categories?post=11075"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/moneycompass.com.my\/cn\/wp-json\/wp\/v2\/tags?post=11075"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}